Veronica Orick, MD
Family Medicine · Gaffney, SCNPI 1134186463
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 8 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Viatris Specialty LLC at 28.8% of the total. 2025 is the largest year on record at $77, 3.6 times the $21 reported in 2022. That places this record below the midpoint for family medicine clinicians in SC, where the typical reported total is $473.
Across 8 payments — averaging $23.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viatris Specialty LLC$53
- Acadia Pharmaceuticals Inc$46
- Inari Medical, Inc.$35
- Mylan Specialty L.p.$27
- Neurocrine Biosciences, Inc.$24
What the payments were for
- Food & beverage$185100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viatris Specialty LLC | 3 | $53 |
| Acadia Pharmaceuticals Inc | 1 | $46 |
| Inari Medical, Inc. | 2 | $35 |
| Mylan Specialty L.p. | 1 | $27 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
How this compares
$185 in reported general payments places this provider in the 35th percentile of 2,153 family medicine providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 268 | $76,845 |
| TrulicityDulaglutide | 29 | $25,271 |
| OzempicSemaglutide | 18 | $18,082 |
| MyrbetriqMirabegron | 74 | $16,652 |
| XareltoRivaroxaban | 56 | $16,068 |
| EntrestoSacubitril/Valsartan | 39 | $13,285 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $11,013 |
| Divalproex Sodium | 96 | $10,545 |
| LinzessLinaclotide | 15 | $8,371 |
| Gabapentin | 262 | $6,616 |
| JardianceEmpagliflozin | 21 | $6,572 |
| BrilintaTicagrelor | 28 | $6,212 |
| Topiramate ErTopiramate | 11 | $5,453 |
| Atorvastatin Calcium | 306 | $4,997 |
| Levetiracetam | 117 | $4,945 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Gaffney
- Stephen BruntonWinnsboro$1.3M
- Richard WilkesMt Pleasant$216K
- Andrew MartinColumbia$205K
- Ada StewartColumbia$186K
- Jeffrey BroderNorth Augusta$140K
- Terry NagelColumbia$112K
- Katherine JohnsonGreenwood$80K
- Scott SmithMount Pleasant$68K
- Jennifer StolinSummerville$59K
- Nicholas PenningsNorth Myrtle Beach$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.